About Flore
Flore is a company based in San Diego (United States) founded in 2016 by Suneer Sunny Jain. Flore has raised $21.12 million across 6 funding rounds from investors including Human Longevity, Plug and Play Tech Center and Pangaea Ventures. The company has 16,436 employees as of October 28, 2024. Flore operates in a competitive market with competitors including Viome, Evvy, Elo Health, uBiome and Ombre, among others.
- Headquarter San Diego, United States
- Employees 16436 as on 28 Oct, 2024
- Founders Suneer Sunny Jain
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sun Pharmaceutical Industries Ltd
- Date of Incorporation 01 Mar, 1993
- Jurisdiction Vadodara, Gujarat, India
-
Annual Revenue
$5.82 B (USD)11.97as on Mar 31, 2024
-
Net Profit
$1.12 B (USD)12.89as on Mar 31, 2024
-
EBITDA
$1.52 B (USD)11.82as on Mar 31, 2024
-
Total Equity Funding
$21.12 M (USD)
in 6 rounds
-
Latest Funding Round
$9.25 M (USD), Series A
Sep 16, 2020
-
Investors
Human Longevity
& 8 more
-
Employee Count
16436
as on Oct 28, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Flore
Flore has successfully raised a total of $21.12M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $9.25 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Flore
Flore has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Human Longevity, Plug and Play Tech Center and Pangaea Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in hard tech for planetary health, focusing on materials science, chemistry, and biology.
|
Locked | Locked | Locked | |
|
Investments are made by K3 Ventures in early-stage technology startups.
|
Locked | Locked | Locked | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Locked | Locked | Locked |
Investor details for Flore
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Flore
Investment portfolio details for Flore
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Flore
Detailed financials for Flore
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Flore Comparisons
Peer comparison for Flore
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Flore
Flore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Evvy, Elo Health, uBiome and Ombre, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| Locked | Locked | Locked |
Vaginal microbiome test kits are provided through an online platform.
|
|
| Locked | Locked | Locked |
Personalized supplements are delivered based on biochemical analysis.
|
|
| Locked | Locked | Locked |
Provides comprehensive sequence datasets for human microbiome research and analysis.
|
|
| Locked | Locked | Locked |
Microbiome-based personalized supplements are offered via gut testing kits.
|
Detailed competitors of Flore
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Flore
Complete news archive for Flore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Flore
Flore was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Flore is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Suneer Sunny Jain is the current CEO of Flore. They have also founded this company.
Flore is a funded company, having raised a total of $21.12M across 6 funding rounds to date.
As of Oct 28, 2024, the latest employee count at Flore is 16,436.
Annual revenue of Flore is $5.82B as on Mar 31, 2024.
Flore was founded in 2016 in San Diego, United States, and operates in the health and wellness sector. Nutritional supplements focused on gut health are offered, including customized probiotics developed from stool sample analysis. These address issues such as bloating, gas, constipation, digestive problems, food tolerance, bowel regulation, and immune support. Services are delivered through personalized testing and product recommendations.
Flore's top competitors include Viome, Evvy and Elo Health.
Flore has 9 investors. Key investors include Human Longevity, Plug and Play Tech Center, Pangaea Ventures, The Orion Fund, and K3 Ventures.